Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

New England Journal of Medicine

Volumn 347, Issue 19, 2002, Pages 1493-1499

  Sousa, Ana R ^a   Parikh, Abhi ^b   Scadding, Glenis ^b   Corrigan, Christopher J ^a   Lee, Tak H ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD45 ANTIGEN; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MALE; NASAL BIOPSY; NOSE MUCOSA; NOSE POLYP; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; RHINOSINUSITIS;

ADULT; AGED; ANTIGENS, CD45; ASPIRIN; ASTHMA; BIOPSY; DESENSITIZATION, IMMUNOLOGIC; DOWN-REGULATION; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RECEPTORS, LEUKOTRIENE; RECEPTORS, LEUKOTRIENE B4; SINUSITIS;

EID: 0037038214     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013508     Document Type: Article

References (30)

1. Samter M, Beers RF. Intolerance to aspirin: Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-83.
2. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
3. 4, and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103.
4. 4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis 1992;146:1531-4.
5. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994;149:940-6.
6. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirinsensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988;137:847-54.
7. Picado C, Ramis I, Rosello J, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992;145:65-9.
8. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206. [Errata, N Engl J Med 1999;340:663, 341:1632.]
9. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
10. Leff AR. Regulation of leukotrienes in the management of asthma: Biology and clinical therapy. Annu Rev Med 2001;52:1-14.
11. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153:572-5.
12. Fischer AR, Rosenberg MA, Lilly CM, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994;94:1046-56.
13. Nasser SM, Pfister R, Christie PE, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996;153:90-6.
14. 1 receptor. Nature 1999;399:789-93.
15. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000;275:30531-6.
16. 1 receptor in normal human lung and peripheral blood leukocytes. Am Rev Respir Crit Care Med 2001;163:226-33.
17. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998;19:453-61.
18. Nicosia S, Capra V, Rovati GE. Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2001;14:3-19.
19. Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991;144:957-8.
20. 4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148-53.
21. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: Tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980;66:82-8.
22. Patriarca G, Nucera E, DiRienzo V, Schiavino D, Pellegrino S, Fais G. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy 1991;67:60-2.
23. 4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care Med 1995;151:1326-30.
24. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for the diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998;101:581-6.
25. Varga EM, Jacobson MR, Masuyama K, et al. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999;14:610-5.
26. Thivierge M, Doty M, Johnson J, Stankova J, Rola-Pleszczynski M. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 2000;165:5221-6.
27. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-90.
28. Diamant Z, Hiltermann JT, Van Rensen EL, et al. The effect of inhaled leukotriene D4 and methacoline on sputum cell differentials in asthma. Am J Respir Crit Care Med 1997;155:1247-53.
29. Patriarca G, Schiavino D, Nucera E, Papa G, Schinco G, Fais G. Prevention of relapse in nasal polyposis. Lancet 1991;337:1488.
30. Scadding GK, Hassab M, Darby YC, Lund VJ, Freedman A. Intranasal lysine aspirin in recurrent nasal polyposis. Clin Otolaryngol 1995;20:561-3.